Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by ragingbull2727 on May 29, 2013 7:42am

Graeme...

Doesn't even say thank you to the TH worker he gets his coffee from in the morning.....

Classy.

Comment by HighteawithIntrepid on May 29, 2013 7:55am
Which store do you work at?
Comment by HighteawithIntrepid on May 29, 2013 8:14am
Ask him when he thinks the the VMC will become a GMP. by July, by August by Sept 21?. Maybe the goal is June 30th, one can only dream. Scrap value 6M, cost 60M, working value say 120M. The poor man has to be stressed to the nines. Such big visions caught up by vulture capitalists, not a bad thing if you just bought  under .25, but one mother if you bought years ago at $1.50 or higher and ...more  
Comment by beechguy on May 29, 2013 9:55am
$1.50 is a lot better than nada! Although I believe our value should be north of $2 with the cash situation cleared up and deals in place. With Urocidin (.50 to .70 up front, plus a dollar for Urocidin once cash and burn is addressed- $1.50 for outright sale), GMP for vaccine plant, (.50 to .70 at least I am told)  Animal health (1.00 to 1.20) MCC Human, Oncocidin Human ...more  
Comment by Bagatrix on May 29, 2013 10:03am
Hi Beech given that you are a knowledgable investor would you say we would be , if everything goes well, back to at least the $1.90 that we were way back when the world was young?
Comment by Nohandledzep on May 29, 2013 10:07am
Beech...These are reasonable valuations, but scenario 1 (Graeme gone in a proxy battle) should precede all of them, or we will be lucky to see 20% of your projected return from each catalyst.   Look at the SP today. The company has publicly said that there is tremendous interest in AH and Urocidin. Clearly, no one of significance cares. Change the board and management, make the same ...more  
Comment by arghh on May 29, 2013 10:21am
I agree. We may see a lot less than is reasonable given who is still in charge. Am I correct when I think the GMP validation is nothing more than a foot dragging exercise?  
Comment by Tson99 on May 29, 2013 10:29am
We have been hearing about potential partnerships for at least 5 months now. When the H E double hockey sticks are they going to make deal????? This is like watching paint dry. GLTA Longs, Tson99
Comment by ragingbull2727 on May 29, 2013 12:07pm
You'll see Graeme at the Bayview Mall Timmy Ho around 8am, slightly earlier.   Of course, you'll be able to tell by the Lexus with "TSX BNC" plates.  
Comment by HighteawithIntrepid on May 29, 2013 1:08pm
Thanks RB OK if you live in Belleville you know when and where to be. Question: How is the VMC coming along Graeme?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities